Paroxetine in pharma franchise in Madhya Pradesh

Paroxetine in PCD pharma franchise in Aizawl

Paroxetine in top pharma company in Jaipur

Paroxetine in pcd pharma supplier in Indore

Paroxetine in phama franchise company in India
Paroxetine in phama distributor in Pune

Home/Products /paroxetine-i-point-p-point-12-point-5mg-prolonged-release-tablets-tablet

Paroxyle 12.5 CR Tablet

Composition : Paroxetine I.P. 12.5mg Prolonged Release Tablets

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹189/-

Paroxyle 12.5 CR contains Paroxetine I.P. 12.5mg in a prolonged-release (CR) formulation, designed for the gradual release of the active ingredient over an extended period. This allows for consistent therapeutic effects and helps reduce side effects associated with peak drug levels. Paroxetine is a selective serotonin reuptake inhibitor (SSRI) primarily used in the treatment of mood disorders.

Paroxyle 12.5 CR is effective in treating conditions like depression, anxiety, and obsessive-compulsive disorder (OCD). By increasing serotonin levels in the brain, Paroxyle helps improve mood, reduce anxiety, and alleviate symptoms of OCD. The prolonged-release formulation provides a steady effect, improving patient compliance and minimizing fluctuations in symptom control.

Read More

About the Product

Paroxyle 12.5 CR contains Paroxetine I.P. 12.5mg in a prolonged-release (CR) formulation, designed for the gradual release of the active ingredient over an extended period. This allows for consistent therapeutic effects and helps reduce side effects associated with peak drug levels. Paroxetine is a selective serotonin reuptake inhibitor (SSRI) primarily used in the treatment of mood disorders.

Paroxyle 12.5 CR is effective in treating conditions like depression, anxiety, and obsessive-compulsive disorder (OCD). By increasing serotonin levels in the brain, Paroxyle helps improve mood, reduce anxiety, and alleviate symptoms of OCD. The prolonged-release formulation provides a steady effect, improving patient compliance and minimizing fluctuations in symptom control.

Common side effects include nausea, dizziness, dry mouth, and sexual dysfunction; serious side effects include suicidal thoughts and serotonin syndrome.

Indicated for major depressive disorder, generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, and social anxiety disorder.

Take as prescribed by your doctor; do not exceed the recommended dose and avoid alcohol.

Store in a cool, dry place away from sunlight and moisture, out of reach of children. Important Notice:

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation